In a recent letter from the makers of Enbrel®, they stated that all patients currently receiving Enbrel® therapy must enroll in the Enrollment Program to ensure that their therapy will not be interrupted beginning January 1, 2001. To enroll, call 1-888-4ENBREL (1-888-42735). All patients wishing to receive Enbrel® therapy as drug becomes available must enroll in the Enrollment Program as well to ensure that their name goes on a waiting list.
Below is an excerpt from that letter:
Immunex and Wyeth-Ayerst have committed substantial resources to support this growing demand. Enbrel®, however, is a highly complex medicine to manufacture, and new production facilities must be built before we can increase supply significantly. These facilities are already under construction. Until they are completed, it is likely that future supplies of Enbrel® may be temporarily limited.
To allow us to identify and accurately count the number of ENbrel® users so we can reserve a place for each of you, Immunex and Wyeth-Ayerst have created the Enbrel®Enrollment Program. The only way to help ensure that your ENBREL therapy is not interrupted is to enroll in the Enrollment Program. If you do not enroll, you will not be able to receive ENBREL beginning January 1, 2001.
The key objective of the program is to help ensure that you and others on Enbrel® continue to receive an uninterrupted supply of medicine.
Enrolling in the program is simple. Just call toll free 1-888-4ENBREL (1-888-42735) to get your Enrollment form. After you return the Enrollment form, we will send you a registration confirmation letter and your personalized Enbrel®Enrollment card.
We urge you to call now. Starting January 1, 2001, you will need an Enbrel®Enrollment card in order to refill your Enbrel® prescription
Receive the Latest News from Johns Hopkins Rheumatology
Join our mailing list to receive the latest news and updates from Johns Hopkins Rheumatology.